targeted therapy – VirentaNews

Investigational therapy blocks common genetic driver of pancreatic cancer

An experimental daily pill has nearly doubled the survival time for patients with advanced pancreatic…

Scientists now classify lung cancer in people who never smoked as a separate entity, with…

Advances in screening, targeted therapies, and molecular understanding are driving a historic decline in lung…

A first-of-its-kind therapy has significantly improved survival in patients with KRAS-mutant pancreatic cancer, a diseas

Elisrasib treatment leads to clinical benefit in NSCLC patients with KRAS G12C mutation

Explore News